StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca total undiscounted contractual maturity of financial liabilities ($M) ($M)

Form 20-F Note 28 — Maturity Analysis of Financial Liabilities (Inline XBRL)

Latest, FY2025
67,268
Period ended Dec 31, 2025
Change on a year earlier
+4.2%
64,574 in FY2024
History
6 years
Since FY2020
Sources
3
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal undiscounted contractual maturity of financial liabilities ($M) ($M)Year on yearSource
FY2025Dec 31, 202567,268+4.2%Form 20-F FY2025 Annual Report ↗
FY2024Dec 31, 202464,574+3.3%Form 20-F FY2025 Annual Report ↗
FY2023Dec 31, 202362,488-2.5%Form 20-F FY2024 Annual Report ↗
FY2022Dec 31, 202264,071-3.1%Form 20-F FY2024 Annual Report ↗
FY2021Dec 31, 202166,119+26.5%Form 20-F FY2023 Annual Report ↗
FY2020Dec 31, 202052,254–Form 20-F FY2023 Annual Report ↗

Breakdown

What makes up total undiscounted contractual maturity of financial liabilities ($m)

Cite this data

StockData. (2026). AstraZeneca Total undiscounted contractual maturity of financial liabilities ($M) ($M), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/fin_liab_undisc_total

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.